Skip to main content

PFTs and the drug trial

I’m home. This will be short as I’ve only been home about five minutes, but being without a computer to write with during these past few days has been like torture for me! I’ve got tons of blogging to catch up on!

I know several of the regular readers want to know how the trip to the National Institutes of Health went. I suppose it went well, all things considered.

The good news is my FVC was better than the one taken at KUMed. The bad news is it wasn’t in the normal range either. They seemed to have a hard time getting a read, but the best one I puffed was an 87, and the worst one (after the abuderol ironically enough) was an 82. The other numbers were all down as well.

They did a high resolution CT scan and it showed two new nodules on my lungs as well as “a patchy area” that seemed to be a point of debate. The good news is no one thought it looked like fibrosis, so they thought it might be from allergies. But, my allergies are actually much improved, so I’m not convinced.

Dr. Gahl said that the results would make me eligible for the drug trial, however. Since I was only there for a single day, I’ve got to go back for a complete weeklong work up within 30 days. So, I’m trying not to assume I’ll be in the trial, even though everyone else at NIH seems to be assuming that. It’s just been too long a road with too many ups and downs. Having my PFTs down is emotionally draining enough without having the rug yanked out from under me again.

How am I doing with this news? Well, it depends on when you ask. I’m emotional about it to say the least. On the one hand, I’ve been hovering around a downward turn for four years, so the chances that I was going to walk in and puff a 100 were pretty slim to none. Given my numbers and scans, the chances that I’d get through the next five years without a big drop are also pretty slim to none. So, given that, I’d just assume be on the top end of eligibility for the trial.

At the same time, this is a trial and there is no other treatment or cure. It’s going to get worse, and we seem to be moving down that road. I won’t know if I’m one of the patients on the drug or not. That’s a very scary thought.

I have lots of other thoughts about it too, but am too drained to share right now. That’s the quick and dirty version!

Also, lots to tell from the Genetic Alliance meeting – stay tuned!

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for...

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria...

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.